A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II diabetes (T2D) and Wegovy for obesity. Ozempic and Wegovy include the same ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

You can bring needles and injectable medicines like EpiPens (for allergies), insulin or Wegovy in your hand luggage. But it’s important to carry a doctor’s note stating your medical condition and the ...

In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Health plan trustees at a Minneapolis- based construction workers union are suing a subsidiary of UnitedHealth Group for paying more than $4 million for costly weight-loss drugs, depleting union funds ...